This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Medical Affairs World Congress

$300 SAVINGS ENDS IN:

  • 00
    Days
  • 00
    Hrs
  • 00
    Mins
  • 00
    Secs
November 7-8, 2022
Delivered as a Hybrid EventInn at Penn a Hilton Hotel, Philadelphia, PA

Nick West, MA, MD, FRCP, FACC
Chief Medical Officer and Divisional Vice President of Medical Affairs at Abbott's vascular business

Profile

Dr. Nick West is the Chief Medical Officer and Divisional Vice-President of Global Medical Affairs of Abbott’s vascular business, a global healthcare company developing life-changing technologies to reduce the burden of cardiovascular disease and improve patients’ lives. He graduated in medicine from Trinity Hall, University of Cambridge and St. Thomas’ Hospital Medical School, London, and trained in interventional cardiology at the John Radcliffe Hospital, Oxford and Green Lane Hospital, Auckland, New Zealand. His post-graduate research in vascular biology, undertaken in the Department of Cardiovascular Medicine, University of Oxford and at Duke University, led to the award of the Sir Lionel Whitby Medal and the Sir Walter Langdon-Brown Prize at the University of Cambridge. Until late 2019 he was a practicing interventional cardiologist at the Royal Papworth Hospital, Cambridge, UK; he has published over 120 peer-reviewed papers & book chapters on topics including coronary physiology/microvascular function, intracoronary imaging/vulnerable plaque detection, acute myocardial infarction and use of bioresorbable scaffolds. He was also a founding member and latterly Chief Medical Officer of the Cambridge-based biotechnology startup, PlaqueTec Ltd.

Dr. West is often invited to speak and host discussions at industry-leading events and sought out by publications and podcasts as an influential voice on the future of vascular health and patient care.

Agenda Sessions

  • Defining Medical’s Role in Determining Patient Engagement Strategy

    2:30pm